Pfizer partners with Enodia Therapeutics in $500m drug deal

​

Pfizer and Enodia Therapeutics have announced a research collaboration and licensing deal potentially worth over $500m to discover and develop Sec61 inhibitors.

The post Pfizer partners with Enodia Therapeutics in $500m drug deal appeared first on Hospital Management.

 

Back to the Featured Stories

Connect with us

Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.